The FDA approved Johnson & Johnson’s ketamine-derived drug for treatment-resistant depression
Share to linkedin
Following early research by the National Institutes of Health, specialized clinics have offered intravenous ketamine treatments for depression on an off-label basis for many years.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Nasal spray drug related to ketamine approved by FDA to treat depressionThe FDA approved esketamine, an experimental nasal spray that delivers the active ingredients of the “club drug” ketamine, as a new treatment for severe depression.
Weiterlesen »
Birth control recall: Pregnancy risk warning issued by FDA after 'packaging error'The FDA warned those using the affected drugs to use alternative precautions to prevent pregnancy.
Weiterlesen »
Silicon Valley just lost a friend with the exit of Gottlieb from the FDASilicon Valley's tech companies like Apple and Alphabet had an ally in FDA commissioner Scott Gottlieb.
Weiterlesen »
Reynolds tobacco debuts e-cigarette commercial, tightens online vape sales to combat teen useReynolds is also tightening online sales as the FDA weighs e-cigarette regulations.
Weiterlesen »
FDA puts 15 national retailers on notice for allegedly selling tobacco products to minorsThe Food and Drug Administration called out 15 retailers on Monday for allegedly selling tobacco products to minors.
Weiterlesen »
FDA calls Walgreens' sale of tobacco to minors 'disturbing'The Food and Drug Administration says Walgreens sells more tobacco products to minors than any other pharmacy chain. Now the agency wants to meet with the company to discuss its tobacco and e-cigarette sales policies.
Weiterlesen »